Tag Archives: OGN stock research
Organon & Co (OGN) 25Q1 Update
Organon (OGN) reported 25Q1 GAAP diluted EPS of $0.33, down from $0.78 a year ago. Non-GAAP EPS was $1.02, down from $1.22. I had anticipated GAAP EPS of $0.61 and non-GAAP EPS of $0.92. Revenues of $1.51 billion declined 6.7% … Continue reading
Posted in Health Care, OGN
Tagged OGN stock research, Organon, Organon & Co.
Comments Off on Organon & Co (OGN) 25Q1 Update
Organon (OGN) 24Q4 Update
24Q4 revenues were $1.59 billion, up 3% at constant currency but down 0.4% YOY and 2.8% below my estimate. GAAP diluted EPS was $0.42, compared with 23Q4’s $2.13 and my estimate of $0.60. Non-GAAP EPS of $0.90 was above last … Continue reading
Posted in Health Care, OGN
Tagged OGN stock research, Organon
Comments Off on Organon (OGN) 24Q4 Update